American Heart Journal
Volume 153, Issue 1 , Pages 90-97 , January 2007

Association of atrial fibrillation and amino-terminal pro–brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: Results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study

  • Angela Morello, MD

      Affiliations

    • Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA
    • ,
  • Donald M. Lloyd-Jones, MD, ScM

      Affiliations

    • Department of Preventive Medicine and Bluhm Cardiovascular Institute, Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, IL
    • ,
  • Claudia U. Chae, MD, MPH

      Affiliations

    • Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA
    • ,
  • Roland R.J. van Kimmenade, MD, PhD

      Affiliations

    • Department of Cardiology, University Hospital Maastricht, Maastricht, The Netherlands
    • ,
  • Annabel C. Chen, MD

      Affiliations

    • Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA
    • ,
  • Aaron L. Baggish, MD

      Affiliations

    • Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA
    • ,
  • Michelle O'Donoghue, MD

      Affiliations

    • Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA
    • ,
  • Elizabeth Lee-Lewandrowski, PhD, MPH

      Affiliations

    • Clinical Laboratories, Massachusetts General Hospital and Harvard Medical School, Boston, MA
    • ,
  • James L. Januzzi Jr, MD

      Affiliations

    • Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA
    • Corresponding Author InformationReprint requests: James L. Januzzi, Jr, MD, Massachusetts General Hospital, Boston, MA 02114.

Received 12 June 2006 ,Accepted 9 October 2006.

References 

  1. Januzzi JL, Camargo CA, Anwaruddin S, et al. The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol. 2005;95:948–954
  2. Januzzi JL, Sakhuja R, O'Donoghue M, et al. Utility of amino-terminal pro–brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department. Arch Intern Med. 2006;166:315–320
  3. Januzzi JL, van Kimmenade R, Lainchbury J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: The International Collaborative of NT-proBNP Study. Eur Heart J. 2006;27:330–337
  4. James SK, Lindahl B, Siegbahn A, et al. N-terminal pro–brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation. 2003;108:275–281
  5. Altintop L, Yardan T, Cander B, et al. An increase of BNP levels in massive pulmonary embolism and the reduction in response to the acute treatment. Resuscitation. 2005;65:225–229
  6. Ellinor PT, Low AF, Patton KK, et al. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. J Am Coll Cardiol. 2005;45:82–86
  7. Knudsen CW, Omland T, Clopton P, et al. Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study. J Am Coll Cardiol. 2005;46:838–844
  8. Levey AS, Berg RL, Gassman JJ, et al. Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney Int Suppl. 1989;27:S73–S80
  9. O'Donoghue M, Chen A, Baggish AL, et al. The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. J Card Fail. 2005;11(5 Suppl):S9–S14
  10. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370–2375
  11. Arima M, Kanoh T, Kawano Y, et al. Plasma levels of brain natriuretic peptide increase in patients with idiopathic bilateral atrial dilatation. Cardiology. 2002;97:12–17
  12. Inoue S, Murakami Y, Sano K, et al. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail. 2000;6:92–96
  13. Koitabashi T, Inomata T, Niwano S, et al. Distinguishable optimal levels of plasma B-type natriuretic peptide in heart failure management based on complicated atrial fibrillation. Int Heart J. 2005;46:453–464
  14. Lee SH, Jung JH, Choi SH, et al. Determinants of brain natriuretic peptide levels in patients with lone atrial fibrillation. Circ J. 2006;70:100–104
  15. Pozzoli M, Cioffi G, Traversi E, et al. Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol. 1998;32:197–204
  16. Rossi A, Enriquez-Sarano M, Burnett JC, et al. Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study. J Am Coll Cardiol. 2000;35:1256–1262
  17. Silvet H, Young-Xu Y, Walleigh D, et al. Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. Am J Cardiol. 2003;92:1124–1127
  18. Tsuchida K, Tanabe K. Influence of paroxysmal atrial fibrillation attack on brain natriuretic peptide secretion. J Cardiol. 2004;44:1–11
  19. Nakamura M, Niinuma H, Chiba M, et al. Effect of the maze procedure for atrial fibrillation on atrial and brain natriuretic peptide. Am J Cardiol. 1997;79:966–970
  20. Ohta Y, Shimada T, Yoshitomi H, et al. Drop in plasma brain natriuretic peptide levels after successful direct current cardioversion in chronic atrial fibrillation. Can J Cardiol. 2001;17:415–420
  21. Vinch CS, Rashkin J, Logsetty G, et al. Brain natriuretic peptide levels fall rapidly after cardioversion of atrial fibrillation to sinus rhythm. Cardiology. 2004;102:188–1893
  22. Watanabe M, Murakami M, Furukawa H, et al. Decreased plasma brain natriuretic peptide levels after a successful maze procedure. J Heart Valve Dis. 2003;12:287–291
  23. Albage A, Kenneback G, van der Linden J, et al. Improved neurohormonal markers of ventricular function after restoring sinus rhythm by the Maze procedure. Ann Thorac Surg. 2003;75:790–795
  24. Jourdain P, Bellorini M, Funck F, et al. Short-term effects of sinus rhythm restoration in patients with lone atrial fibrillation: a hormonal study. Eur J Heart Fail. 2002;4:263–267
  25. Mabuchi N, Tsutamoto T, Maeda , et al. Plasma cardiac natriuretic peptides as biochemical markers of recurrence of atrial fibrillation in patients with mild congestive heart failure. Jpn Circ J. 2000;64:765–771
  26. Rashidi A. Mechanism of high brain natriuretic peptide in patients with atrial fibrillation. Am J Cardiol. 2004;93:670
  27. Doyama K, Fukumoto M, Takemura G, et al. Expression and distribution of brain natriuretic peptide in human right atria. J Am Coll Cardiol. 1998;32:1832–1838
  28. Frustaci A, Chimenti C, Bellocci F, et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997;96:1180–1184
  29. Nishigaki K, Tomita M, Kagawa K, et al. Marked expression of plasma brain natriuretic peptide is a special feature of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 1996;28:1234–1242
  30. Tuinenburg AE, Brundel BJ, Van Gelder IC, et al. Gene expression of the natriuretic peptide system in atrial tissue of patients with paroxysmal and persistent atrial fibrillation. J Cardiovasc Electrophysiol. 1999;10:827–835
  31. Beck-da-Silva L, de Bold A, Fraser M, et al. Brain natriuretic peptide predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm. Can J Cardiol. 2004;20:1245–1248
  32. Wazni OM, Martin DO, Marrouche NF, et al. Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation. 2004;110:124–127
  33. O'Toole L, McLean KA, Channer KS. Pulmonary embolism presenting with atrial fibrillation. Lancet. 1993;342:1050
  34. Raggi P, Vasavada BC, Parente T, et al. Uncommon etiologies of atrial fibrillation. Clin Cardiol. 1996;19:513–516
  35. Pruszczyk P, Kostrubiec M, Bochowicz A, et al. N-terminal pro–brain natriuretic peptide in patients with acute pulmonary embolism. Eur Respir J. 2003;22:649–653
  36. Pruszczyk P, Szulc M, Kostrubiec M. Potential clinical application of brain natriuretic peptides in acute pulmonary embolism. Eur Heart J. 2004;25:621
  37. Sohne M, Ten M, Wolde HR. Biomarkers in pulmonary embolism. Curr Opin Cardiol. 2004;19:558–562

PII: S0002-8703(06)00895-7

doi: 10.1016/j.ahj.2006.10.005

American Heart Journal
Volume 153, Issue 1 , Pages 90-97 , January 2007

Article Tools

* Image Usage & Resolution